title: [Molecular targeting agents for multiple myeloma].
authors.affiliation: Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences.
authors.forename: Shiro
authors.initials: S
authors.lastname: Fujii
authors.forename: Masahiro
authors.initials: M
authors.lastname: Abe
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001896:Boron Compounds / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D005998:Glycine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006655:Histone Deacetylases / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007783:Lactones / Q000627:therapeutic use; D000077269:Lenalidomide; D058990:Molecular Targeted Therapy / Q000379:methods*; D009101:Multiple Myeloma / Q000188:drug therapy*; D009842:Oligopeptides / Q000627:therapeutic use; D061988:Proteasome Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001896:Boron Compounds; D001897:Boronic Acids; D007155:Immunologic Factors; D007783:Lactones; D009842:Oligopeptides; D061988:Proteasome Inhibitors; D011719:Pyrazines; D011758:Pyrroles; C546027:elotuzumab; D013792:Thalidomide; D000069286:Bortezomib; C475865:marizomib; C548400:ixazomib; C524865:carfilzomib; D006655:Histone Deacetylases; D000077269:Lenalidomide; D005998:Glycine